We are live on ! Find out more
RXST icon

RxSight

74 hedge funds and large institutions have $264M invested in RxSight in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

885% more call options, than puts

Call options by funds: $1.15M | Put options by funds: $117K

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

278% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 9

118% more capital invested

Capital invested by funds: $121M → $264M (+$143M)

28% more funds holding

Funds holding: 5874 (+16)

12.25% more ownership

Funds ownership: 34.68%46.92% (+12%)

Holders
74
Holders Change
+16
Holders Change %
+27.59%
% of All Funds
1.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
34
Reduced
9
Closed
5
Calls
$1.15M
Puts
$117K
Net Calls
+$1.03M
Net Calls Change
+$795K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$50.9M
Artisan Partners
2
Artisan Partners
Wisconsin
$44.1M +$37.4M +2,646,641 New
BlackRock
3
BlackRock
New York
$20.8M +$3.15M +222,907 +22%
O
4
OrbiMed
New York
$20.1M
Vanguard Group
5
Vanguard Group
Pennsylvania
$17M +$3.15M +223,228 +28%
NCGI
6
Next Century Growth Investors
Minnesota
$14.6M +$3.23M +228,468 +35%
Millennium Management
7
Millennium Management
New York
$11.4M +$4.07M +288,300 +73%
JP Morgan Chase
8
JP Morgan Chase
New York
$9.43M +$7.82M +553,820 +4,739%
DCM
9
Driehaus Capital Management
Illinois
$7.84M +$6.64M +469,890 New
PHP
10
Parkman Healthcare Partners
Connecticut
$7.14M +$3.55M +251,372 +142%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$6.65M +$1.33M +93,869 +31%
State Street
12
State Street
Massachusetts
$6.14M +$1.04M +73,869 +25%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$5.81M +$1.28M +90,468 +35%
Lord, Abbett & Co
14
Lord, Abbett & Co
New Jersey
$5.65M +$4.78M +338,790 New
Northern Trust
15
Northern Trust
Illinois
$3.08M +$407K +28,822 +19%
EI
16
EAM Investors
California
$2.87M +$2.43M +171,879 New
Invesco
17
Invesco
Georgia
$2.22M +$1.88M +132,899 New
SSA
18
Schonfeld Strategic Advisors
New York
$2.06M +$1.07M +75,600 +158%
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$1.91M +$1.44M +102,147 +831%
BAM
20
Belpointe Asset Management
Nevada
$1.76M +$1.49M +105,250 New
BM
21
Bridger Management
New York
$1.65M +$1.4M +99,100 New
MF
22
Magnetar Financial
Illinois
$1.47M -$1.16M -81,905 -48%
SCM
23
Soleus Capital Management
Connecticut
$1.33M +$1.13M +80,000 New
Goldman Sachs
24
Goldman Sachs
New York
$1.28M +$1.09M +76,969 New
PAMP
25
Polar Asset Management Partners
Ontario, Canada
$1.25M +$1.06M +75,181 New

RXST Hedge Fund Activity: Q1 2023 in Review

74 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2023, worth a combined $264M — up 118% from $121M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RXST positions and 5 closed out — a net gain of 16 holders — while 34 added to existing stakes and 9 trimmed.

The largest buyer was Artisan Partners, opening a new position worth an estimated $37.4M. The largest seller was Cresset Asset Management, exiting entirely with an estimated $3.84M sold.

  • 74 institutional investors held RxSight (RXST) as of Q1 2023, up from 58 in Q4 2022.
  • Funds reported $264M of RxSight stock for Q1 2023, up 118% quarter-over-quarter.
  • 21 funds opened new RxSight positions in Q1 2023 and 5 closed out, a net change of +16 holders.
  • The largest RxSight buyer in Q1 2023 was Artisan Partners, an estimated $37.4M added.
  • The largest RxSight seller in Q1 2023 was Cresset Asset Management, an estimated $3.84M sold.

Based on aggregated 13F filings for Q1 2023.